Loading data for EIS — first visit, this takes a few seconds.
iShares MSCI Israel ETF (EIS)
NYSEArca: EIS
· 即時價格 · USD
122.73
-2.41 (-1.93%)
收盤價： Aug 31, 2026, 5:57 PM
iShares MSCI Israel ETF（EIS）ETF 價格、持股與分析
| 買價 | 120 |
| 市值 | 不適用 |
| AUM | 879.31M |
| 資產淨值 | 125.38 |
| 貝他值 | 1.07 |
| EPS (ttm) | 不適用 |
| 本益比（ttm） | 17.79 |
| 分享出去 | 2.55M |
| 成立日期 | Mar 26, 2008 |
| 賣價 | 125.7 |
| 成交量 | 13,051 |
| 20 日平均成交量 | 67,871 |
| 開盤價 | 124.72 |
| 前收盤價 | 125.14 |
| 當日區間 | 123.02 - 124.73 |
| 52 週範圍 | 91.14 - 138.85 |
| 持股 | 不適用 |
| 總費用率 | 0.59% |
關於 EIS
The fund generally will invest at least 80% of its assets in the component securities of the underlying index and in investments that have economic characteristics that are substantially identical to the component securities of the underlying index. The index is a free float-adjusted market capitalization-weighted index rhat is designed to measure the performance of the large-, mid- and small-capitalization segments of the equity market in Israel. The fund is non-diversified.
熱門產業
| 類股 | 重量% |
|---|---|
| Financial Services | 34.55% |
| Technology | 18.67% |
| Industrials | 10.83% |
| Healthcare | 10.55% |
| Real Estate | 8.35% |
十大持股 53.48 資產%
| 名稱 | 代號 | 重量 |
|---|---|---|
| Teva Pharmaceutical ... | TEVA | 10.1% |
| Bank Leumi Le-israel... | LUMI.TA | 8.66% |
| Bank Hapoalim Bm | POLI.TA | 7.86% |
| Tower Semiconductor ... | TSEM.TA | 6.12% |
| Elbit Systems Ltd | ESLT.TA | 5.57% |
| Phoenix Financial Lt... | PHOE.TA | 3.17% |
| Israel Discount Bank... | DSCT.TA | 3.16% |
| Nova Ltd | NVMI | 3.03% |
| Enlight Renewable En... | ENLT.TA | 2.93% |
| Mizrahi Tefahot Bank... | MZTF.TA | 2.88% |
股利 股利殖利率 1.52%
| 前股利 | 金額 | 付款日期 |
|---|---|---|
| Jun 15, 2026 | $0.7720 | 不適用 |
| Dec 16, 2025 | $1.0890 | 不適用 |
| Jun 16, 2025 | $0.4920 | 不適用 |
| Dec 17, 2024 | $0.5480 | 不適用 |
| Jun 11, 2024 | $0.5170 | 不適用 |
9 月前 · Investor's Business Daily
Israel Has Been Mired In Controversy During Its War With Hamas. Big Tech Investment Tells A Different Story.Israel's stock market has outpaced U.S. markets since Oct. 7, 2023, with U.S.-traded leaders like Teva, Elbit Systems and Tower Semiconductor showing big gains.